Lomustine, cytarabine, cyclophosphamide, etoposide – An effective conditioning regimen in autologous hematopoietic stem cell transplant for primary refractory or relapsed lymphoma: Analysis of toxicity, long-term outcome, and prognostic factors-Reference-Cited by-同舟云学术

Lomustine, cytarabine, cyclophosphamide, etoposide – An effective conditioning regimen in autologous hematopoietic stem cell transplant for primary refractory or relapsed lymphoma: Analysis of toxicity, long-term outcome, and prognostic factors

Published:2018 Issue:5 Volume:14 Page:926
ISSN:0973-1482
Container-title:Journal of Cancer Research and Therapeutics
language:en
Short-container-title:J Can Res Ther

Author:

Khattry Navin,Gupta Alok,Gokarn Anant,Rajamanickam Deepan,Punatar Sachin,Thippeswamy Ravi,Mathew Libin,Bagal Bhausaheb,Kannan Sadhana

Publisher

Medknow

Subject

Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence of acute oral mucosal damage secondary to the use of systemic antineoplastics: A systematic review and meta-analysis;Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology;2023-03

2. Outcome of CBV (Carmustine, Cyclophosphamide, Etoposide) Conditioning Regimen for Autologous Stem Cell Transplant in Lymphoma: A Retrospective Study from a Tertiary Cancer Center in South India;Indian Journal of Medical and Paediatric Oncology;2022-02-02

3. Neutrophil decline rate following autologous transplant for lymphoma is a predictor of patients’ outcome;Leukemia & Lymphoma;2021-12-29

4. Disease Status at Transplant has a Significant Impact on Outcomes of Autologous Transplantation (ASCT) in Patients with Hodgkin Lymphoma—A Single Center Experience;Indian Journal of Hematology and Blood Transfusion;2021-05-27

5. A Retrospective Comparison of Mitoxantrone-Melphalan and BEAM Conditioning Regimens Before Autologous Hematopoietic Stem Cell Transplantation in Relapsed/Refractory Lymphoma Patients;Indian Journal of Hematology and Blood Transfusion;2021-05-05